You searched for "Simulation"

2563 results found

Lens surgery in patients with lens subluxation misdiagnosed as primary angle-closure glaucoma

Lens subluxation can be caused by many conditions including Marfan syndrome and other hereditary conditions, and blunt trauma. Lens displacement can cause pupillary block and angle closure. This is commonly misdiagnosed as primary angle closure glaucoma (PACG), which can lead...

How to get the most out of your medical school ophthalmology placement

Ophthalmology has become a very popular speciality, generating a vast interest amongst medical students with competition for training posts increasing yearly. Yet it is often difficult to get adequate exposure to the speciality prior to applications, with very limited time...

Orbis achieves WHO trachoma elimination threshold in Sheka Zone, Southwest Ethiopia

Ahead of World Neglected Tropical Diseases (NTD) Day on 30 January, international eye care charity Orbis has announced that it has achieved the World Health Organisation (WHO) threshold for eliminating trachoma as a public health concern in Sheka Zone, Southwest...

An interview with a glaucoma consultant: Insights for aspiring trainees

In this article, Resident Doctor Chi Kit Yan sits down with Consultant Glaucoma Specialist Salman Sadiq and explores the daily life of a glaucoma specialist, the pros and cons of the role, how trainees can prepare for this subspecialty, and...

Orbis UK release 2024 highlights video

Orbis UK have released their 2024 highlights video, revealing some of the incredible achievements their supporters helped make possible last year. The Orbis Flying Eye Hospital completed two sight-saving missions to Mongolia and Bangladesh. Orbis's clinical staff and Volunteer medical...

Renewed momentum in ocular gene and cell therapy, broadening application to chronic disease

Gene and cell therapies offer the prospect of ground-breaking new avenues for the treatment of diseases, reflected in a renewed explosion of interest and investment in retinal gene therapy. Rod McNeil reports recent clinical trial readouts across a diverse range...

Pharmacopoeia of the Royal Infirmary of Edinburgh

The compact volume depicted in Figure 1 bears the simple title Pharmacopoeia. The book originally belonged to the author’s father, the late John King. A pharmacist by profession, John King maintained a keen interest in matters pertaining to pharmaceutical history....

International Women’s Day 2025: In Conversation With Dr Michelle Le Cheminant

Women make up 70% of the global health and social workforce but hold only 25% of leadership roles. In ophthalmology, women represent just 25-30% of ophthalmologists. Research shows that hospitals with increased female surgeons and anesthetists have lower odds of...

COVID-19 and Charles Bonnet Syndrome

As COVID-19 rips through the country, it is – of course – imperative that we stay at home to try and prevent the virus spreading through the whole community. We are all aware of the need to take special care...

Management options for microphthalmia with orbital cyst with / without visual potential

The authors present six cases (seven eyes) of congenital microphthalmia and orbital cyst. These cases were newborn mainly with one aged 20 years. There were four females and two males and two of seven eyes had a visual potential of...

My Top Five: Emerging technologies revolutionising ophthalmology

Advancements in ophthalmology have significantly transformed eyecare practices. This article explores five emerging technologies that are revolutionising the field, from virtual reality (VR) surgical training to novel therapies for corneal conditions. These innovations are reshaping how eyecare professionals diagnose, treat...

Glaukos Launches iStent infinite® in the UK Following MDR Approval

Glaukos has announced the launch of its latest glaucoma treatment, iStent infinite®, in the UK market after securing approval under the European Medical Device Regulation (MDR). This new approval process is rigorous and provides ophthalmologists with reassurance regarding the efficacy...